Rare Diseases
From the Journals
TNF inhibitors linked to inflammatory CNS events
The authors do not caution “against using these therapies in appropriate patients,” and it is unclear whether this association “represents de novo...
News
COVID-19 linked to development of myasthenia gravis
Italian researchers report three cases of myasthenia gravis onset after COVID-19 infection.
From the Journals
Sarcoidosis may raise long-term risk of heart failure and death
Patients with sarcoidosis have an increased risk of heart failure and other adverse outcomes, including all-cause mortality.
News
Terlipressin squeaks by FDA review for hepatorenal syndrome 1
The FDA advisory committee’s 8-7 vote favoring approval of terlipressin for hepatorenal syndrome type 1 reflected concerns and misgivings.
News
FDA approves first oral somatostatin analog for acromegaly
The oral drug octreotide offers an alternative to long-term injections for the rare chronic disease.
News
FDA approves new treatment for Dravet syndrome
Children treated with fenfluramine experienced significantly greater reductions in the frequency of convulsive seizures than did their peers who...
News
First reported U.S. case of COVID-19 linked to Guillain-Barré syndrome
The unique clinical features in the U.S. case are urinary retention secondary to dysautonomia and ocular symptoms of...
Conference Coverage
Be vigilant for scleroderma renal crisis
Thirty percent of patients with scleroderma renal crisis present atypically.
News
Two rare neurologic conditions linked to COVID-19
Two variants of Guillain-Barré syndrome—Miller Fisher syndrome and polyneuritis cranialis—have been linked with COVID-19 infection.
Conference Coverage
A case of neutrophilic eccrine hidradenitis attributed to HIV treatment
The most common causes of NEH are hematologic malignancies and some of the chemotherapeutic agents used in treating them.
News
First case of COVID-19 presenting as Guillain-Barré reported
A case report from China suggests a possible association between GBS and SARS-CoV-2 infection.